Table 2.

Baseline characteristics and outcomes of individuals stratified by anemia and LVH statusa

LVHAnemia
Absent(n = 2228)Present(n = 131)Absent(n= 2112)Present(n = 287)
Demographics (%)
    age (yr)69.0 ± 11.073.1 ± 9.069.1 ± 10.872.1 ± 11.2
    male37.9b43.5b37.546.0
    white91.177.193.269.0
    high school graduate68.2c58.9c68.960.0
Medical history (%)
CVD29.359.530.8c36.9c
    diabetes16.8b20.6b16.224.7
    hypertension67.493.167.978.0
    currently smokes15.2b16.0b15.99.4
    currently drinks50.0b50.0b51.038.9
Physical characteristics
    BMI (kg/m2)27.1 ± 4.625.9 ± 3.627.1 ± 4.5c26.4 ± 5.0c
    systolic BP134.6 ± 22.3150.6 ± 26.7135.1 ± 22.6139.9 ± 25.6
    diastolic BP72.9 ± 11.7b73.8 ± 13.8b73.2 ± 11.671.0 ± 13.4
    LVH (%)5.1c8.7c
Laboratory results
    creatinine, calibrated (mg/dl)1.3 ± 0.31.5 ± 0.51.3 ± 0.31.6 ± 0.6
    GFR (ml/min per 1.73 m2)51.2 ± 8.147.5 ± 10.651.7 ± 7.545.9 ± 11.5
    total cholesterol (mg/dl)222.3 ± 45.9b218.5 ± 44.0b223.2 ± 45.0211.5 ± 50.4
    HDL cholesterol (mg/dl)50.4 ± 15.8b49.4 ± 16.8b50.2 ± 15.5b51.5 ± 17.8b
    HCT (% packed cell volume)42.2 ± 4.6c41.3 ± 5.1c43.2 ± 3.834.6 ± 2.9
    anemia (%)11.4c18.5c
Clinical outcomes (%)
    cardiac17.234.417.5c23.3c
    stroke10.022.910.5d14.3d
    mortality33.365.632.656.4
    composite41.974.041.463.1
Follow-up (mo)91.9 ± 31.568.0 ± 37.393.1 ± 30.869.1 ± 35.9
  • a Continuous variables are mean ± SD. CVD, cardiovascular disease; BMI, body mass index; HCT, hematocrit.

    All P values are <0.01 when compared within the LVH or anemia status except as follows:

  • b P > 0.05,

  • c P < 0.05, and

  • d P = 0.05.